Closing The Gap: TRICAST Debuts New Gaps In Care Analysis Product
MILWAUKEE, March 28, 2013 /PRNewswire/ -- TRICAST today announced the debut of its new Gaps in Care Analysis product, a set of analytic tools that enable any organization to gauge the effectiveness and performance of its wellness and preventive medicine programs.
What Are Gaps in Care?
Gaps in Care, sometimes referred to as Gaps in Coverage, are found by identifying the discrepancies between recommended best practice medical care, and the medical care that is actually provided to a patient. The gaps generally result from obstacles that prevent patients from implementing a physician's recommendations."TRICAST's Gaps in Care approach focuses on the key diseases linked to both high-cost medical programs and complex medical conditions. The value of the TRICAST analysis lies in our ability to proactively identify members who are receiving less than optimal treatment and then direct them to more active care management, or medical therapy management programs," says TRICAST President Greg Rucinski, R.Ph. The Data Holds the Answers TRICAST begins a Gaps in Care analysis by examining medical, pharmacy, and episodes of care data. After it ingests the data and uses its proprietary software tools to analyze these crucial components, TRICAST identifies and portrays diagnoses, procedure codes, and pharmaceutical treatments. Disease State Profiles Armed with this information, TRICAST can profile disease states and their associated costs by comparing the "best practice" treatment of a disease state to actual patterns of treatment. The reports that result define the gaps in care for these disease states:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Coronary Artery Disease
- Chronic Obstructive Pulmonary Disease with Asthma
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts